Please login to the form below

Not currently logged in

Polleo Pharma co-founders join Chronos Therapeutics

Dr Fraser Murray and Dr Timonthy Schulz-Utermoehl become pre-clinical development VPs

Chronos Dr Fraser MurrayOxford, UK-based Chronos Therapeutics has appointed Dr Fraser Murray and Dr Timothy Schulz-Utermoehl as vice presidents of pre-clinical development.

Together, they will oversee three pre-clinical research programmes recently acquired by the privately-held biotech, which target fatigue in multiple sclerosis, addictive behaviours and post-traumatic stress disorder, respectively.

Dr Murray (pictured above) brings over 20 years of drug discovery and early development experience to the role, spread across a range of therapeutic areas including dermatology, inflammation, neurodegeneration, psychiatry.

Prior to co-founding Polleo Pharma in 2014, Dr Murray served as senior director and head of discovery biology for Shire Specialty Pharmaceuticals, with a focus on central nervous system and gastrointestinal disorders.

He has also held a number of leadership roles at AstraZeneca, Calcico Therapeutics and Merck & Co.

Chronos Dr Timothy Schulz-UtermoehlMeanwhile, Dr Schulz-Utermoehl (pictured left) brings 17 years of early- and late-stage discovery research and preclinical development expertise to Chronos.

As well as co-founding Polleo Pharma alongside Dr Murray, he has worked at AstraZeneca, Merck & Co, Novo Nordisk and, most recently, Shire, where he served as a director in its exploratory projects department in the UK.

Chief executive officer of Chronos Dr Huw Jones said: “We are delighted to welcome Fraser and Timothy to Chronos at a time of significant expansion of our research portfolio.

“They bring substantial pre-clinical development expertise to our organisation and are synergistic to our recent acquisition.
“In particular, their experience as co-founders of Polleo will be invaluable as we advance our behavioural brain disease portfolio.”

4th August 2016

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company

Transforming healthcare outsourcing. From small beginnings in 1997, Ashfield has grown rapidly into an international healthcare services organisation. By anticipating...

Latest intelligence

The Biosimilar Challenge
How health behaviours and clinical outcomes are related
When HCPs understand patient activation levels they can actively guide patients towards more confident self-management of diverse health concerns....
The Periodic Table of Healthcare Communications
The definitive framework for building healthcare communication strategies and plans. Covering Brand Planning, Customer Experience and Multi-channel Marketing....